Keenova partnered with Atorus to bring its clinical data in-house. The biopharma replaced manual trackers with a single source of truth for trial status to accelerate delivery and establish data oversight.\n<\/p>\n
\nKeenova and Atorus accelerated startup timelines by conducting a side-by-side SOP review. Leading with Atorus\u2019 frameworks enabled faster study builds, allowing Keenova to refine its own internal standards as the project progressed.\n<\/p>\n
\nKeenova and Atorus bypassed full-scale system implementation by using Veeva\u2019s standard applications, allowing the teams to focus on study-specific validation. The clear distinction between IT-led system changes and protocol-specific builds ensures stakeholders stay in their defined lanes, reduces administrative burden, and accelerates the path to study launch.\n<\/p>\n
\nUsing existing standards for study builds and automating critical-to-quality (CtQ) checks through Veeva DQS, Keenova and Atorus drive efficiency by building a library of reusable assets for future trials. Real-time dashboards replace manual trackers, providing instant oversight and a single source of truth for study status.\n<\/p>\n
\nKeenova, Atorus, and Veeva leveraged each others\u2019 expertise, frequently communicated, and shifted away from traditional hierarchies, to drive success with a shared strategy.\n<\/p>\n